Relationship between red cell distribution width and prognosis of patients with osteosarcoma.
We retrospectively collected the clinical data and follow-up information of patients with osteosarcoma who were admitted to Department of Orthopedics, RenMin Hospital of Wuhan University from January 2010 and December 2016 and explore the relationship between RDW and prognosis of patients with osteosarcoma. This study finally included 271 patients with osteosarcoma with median follow-up time of 24.2 months (3-69 months). According to the RDW median, 135 patients belongs to the low RDW group, and 136 patients belongs to high RDW group. Compared with low RDW group, the high RDW group tend to have metastasis (50% vs 32.6%, P=0.004), higher poor response rate to chemotherapy compared to the low RDW group (24.3% vs 7.4%, P=0.000) and higher C-reactive protein (7.6±4.9 vs 5.5±4.5, t=3.727, P=0.000). There was slightly significant difference in the types of pathology (χ2=8.059, P=0.045). The Kaplan-Meier analysis indicated survival curve of high RDW group was poorer than that in the low RDW group (P=0.020). The univariate cox analysis indicated that patients with RDW {greater than or equal to} median had higher risk of poor prognosis compared with those who had RDW level< median (HR=2.41, 95%CI:1.51-3.83, P=0.000). After adjusting some potential cofounding factors, the elevated RDW was still associated with poor prognosis (HR=1.66, 95%CI:1.07-2.56, P=0.024). The elevated pretreatment RDW was associated with poor overall survival in patients with osteosarcoma and can be an independent predictor of prognosis.